Get Full Government Meeting Transcripts, Videos, & Alerts Forever!
Get email alerts on the Faqs And Guidance topic
No spam. Unsubscribe anytime.
Committee refers updated AB1286 and ADDS FAQs to full board, members urge clearer language and DEA coordination
Summary
The Enforcement and Compounding Committee recommended that the full board consider staff updates to FAQs implementing AB1286 and automated drug‑dispensing system (ADDS) guidance, emphasizing clearer organization, definitions, a user‑friendly structure and checking for DEA overlap on controlled‑substance guidance.
The committee on April 16 referred staff updates to two sets of frequently asked questions — clarifications related to Assembly Bill 1286 (medication‑error reporting) and reorganized FAQs for automated drug dispensing systems (ADDS) — to the full California State Board of Pharmacy for consideration.
Staff said the AB1286 FAQs were last updated in October 2025 and proposed a new question clarifying infusion‑center pharmacy reporting requirements. Members praised the updates but recommended editorial improvements for clarity and grammar before the full board. "We can certainly... make sure that those kinds of language issues are updated," the chair said.
On ADDS FAQs, members commended staff for reorganizing and recategorizing questions to reduce confusion about which systems require an application. "I really like it. It highlights that when a pharmacy has a robot as a counting machine you do not have to do the application," member Renee Barker said. Several members suggested a table of contents or clearer sectioning so users could jump to licensing, medication‑error reporting, or other topics.
Public commenters flagged additional user issues. Stacy Neron, a healthcare attorney, asked whether the board coordinates with the Drug Enforcement Administration on ADDS and controlled‑substance questions, noting possible conflicts in how DEA divisions interpret requirements. "It would be nice if you collaborated," she said. The committee avoided answering during public comment but agreed to take the concern back to staff.
Sean Kim of the California Pharmacists Association suggested defining acronyms (for example, distinguishing "AUDS" vs. "ADDS") and fixing a broken hyperlink to the complaint form. Members and commenters urged retaining clarifying question 13, which explains when an event does not trigger medication‑error reporting — members said that reassurance helps licensees.
The committee indicated consensus to refer both FAQ updates to the full board for discussion and possible action.
